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Abstract
Background: As previously reported there is evidence for a reduction in right to left shunt (RLS) in stroke patients
with patent foramen ovale (PFO). This occurs predominantly in patients with cryptogenic stroke (CS). We therefore
analysed factors associated with a shunt reduction on follow-up in stroke patients suffering of CS.
Methods: On index event PFO and RLS were proven by transesophageal echocardiography and contrast-enhanced
transcranial Doppler-sonography (ce-TCD). Silent PE was proved by ventilation perfusion scintigraphy (V/Q) within
the stroke work-up on index event; all scans were re-evaluated in a blinded manner by two experts. The RLS was
re-assessed on follow-up by ce-TCD. A reduction in shunt volume was defined as a difference of ≥20 microembolic
signals (MES) or the lack of evidence of RLS on follow-up. For subsequent analyses patients with CS were
considered; parameters such as deep vein thrombosis (DVT) and silent pulmonary embolism (PE) were analysed.
Results: In 39 PFO patients suffering of a CS the RLS was re-assessed on follow-up. In all patients (n = 39) with CS
a V/Q was performed; the median age was 40 years, 24 (61.5%) patients were female. In 27 patients a reduction in
RLS was evident. Silent PE was evident in 18/39 patients (46.2%). Factors such as atrial septum aneurysm, DVT or
even silent PE were not associated with RLS dynamics. A greater time delay from index event to follow-up
assessment was associated with a decrease in shunt volume (median 12 vs. 6 months, p = 0.013).
Conclusions: In patients with CS a reduction in RLS is not associated with the presence of a venous embolic
event such as DVT or silent PE. A greater time delay between the initial and the follow-up investigation increases
the likelihood for the detection of a reduction in RLS.
Background
As previously reported there is evidence for a reduction
in right to left shunt (RLS) or even a functional closure
of a patent foramen ovale (PFO) on follow-up with pre-
dominance in patients with cryptogenic stroke (CS) [1].
As a functional PFO closure was observed after treat-
ment of acute massive pulmonary emboli, a fluctuation
in pulmonary atrial pressure might be involved in the
mechanism of shunt dynamic across a PFO [2-4]. Con-
sidering that silent pulmonary embolism (PE) is a fre-
quent finding in patients with CS and PFO, it raises the
question whether an increase in right atrial pressure due
to silent pulmonary embolism may have a similar
impact on the development of RLS dynamics [5]. We
therefore investigated the relevance of silent PE in a
cohort of PFO patients with CS with a re-assessment of
RLS on follow-up.
Methods
Patients
The eligibility for the study entry was proved by reviewing
case files from consecutive patients. The inclusion criteria
were as follows: stroke or transient ischemic attack (TIA),
RLS and PFO proven by transesophageal echocardiogra-
phy (TEE) and contrast-enhanced transcranial Doppler/
duplex ultrasound (ce-TCD), past index event at least one
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informed consent the RLS was re-assessed by ce-TCD.
Among 130 eligible patients, 39 patients suffering of CS
were re-assessed with respect to shunt persistence. For
categorize the ischemic stroke subtypes criteria established
in the Trial of Org 10172 in Acute Stroke Treatment
(TOAST) were used [6]; in contrast to determined etiolo-
gies (large-artery atherosclerosis, cardioembolism, small-
vessel occlusion, and strokes of other determined etiolo-
gies) in patients with strokes of undetermined etiology
(also termed as cryptogenic strokes) the PFO and the para-
doxical embolism represented the single cause of stroke
which comes into consideration.
Baseline demographic and clinical information were
derived from a stroke registry in which the patients had
been included prospectively, and additionally from case
notes recorded at the index event (T0) [7]. On follow-
up assessment (T1) the following information was
recorded systematically: treatment administrated during
follow-up period and time interval between index event
and follow-up visit (T0-T1) in months.
The study protocol war reviewed and approved by the
ethical committee of the Justus Liebig University Giessen.
ce-TCD
A 2 MHz probe (Philips HP SONOS 5500, Philips Health-
care, Hamburg, Germany) was used to carry out the ce-
TCD. The contrast agent, based on a D-galactose micro-
particle solution (Echovist™, Bayer Vital, Berlin, Ger-
many), was prepared according to the manufacturer’s
instructions, and injected into a large cubital vein of the
left arm. The contrast agent was administered as two sepa-
rate boluses of 5 ml each, one while normal respiration
and the other while a 10 seconds Valsalva strain. The Val-
salva manoeuvre was practiced with the patient before the
procedure. The examination was performed standardized
according to the recommendations of the international
consensus meeting [8]. A curtain pattern was considered
when an individual MES count was not possible.
On follow-up the examiner carrying out the ce-TCD
did not have access to clinical data and initial measure-
ments. All examinations (T0 and T1) were evaluated off-
line by two experts in a standardized protocol, blinded
from any clinical data and the individual chronological
order. In case evaluations were graded differently (differ-
ent MES count), a consensus read was undertaken. A
change in shunt volume was defined as a difference of
≥20 microembolic signals (MES) or no evidence of RLS
on follow-up examination.
TEE
TEE was performed by experienced echocardiographers
from the Department of Cardiology using a 4-7 MHz
multi-plane probe (HP Sonos 5500, Philips Healthcare,
Hamburg, Germany). The same examiner carried out
95% of the TEEs.
To detect an intracardiac shunt, 10 ml of the contrast
agent (Echovist™, Bayer Vital, Berlin, Germany) was
administered by bolus injection into a large antecubital
vein. RLS was evident if the transit of microbubbles
from the right to the left atrium occurred spontaneously
or during a subsequent Valsalva strain. PFO was diag-
nosed when at least three microbubbles were detected
in the left atrium within three heart beats after appear-
ance in the right atrium. An atrial septal aneurysm
(ASA) was diagnosed when the atrial septum extended
at least 11 mm into the left or the right atrium, or both.
An excursion of minimum 5 mm of the septum primum
into either the left or right atrium with respect to a per-
pendicular line to the fossa ovalis plane was considered
as hypermobile atrial septum (HAS).
Ventilation/perfusion scintigraphy (V/Q)
In patients with CS and proven PFO a V/Q was underta-
ken while hospitalisation for the index event as part of
the routine workup. The radioaerosol delivery system
VENTICIS II™ was used for nebulizing a solution of
Tc99m-DTPA. For perfusion scintigraphy 90 MBq of
Tc99 m labelled albumine macroaggregates were slowly
injected intravenously during 3-4 breath cycles. Image
acquisition was performed with a Siemens MultiSpect III
gamma camera. Projection data were scatter corrected
and reconstructed as for single photon emission tomo-
graphy (SPECT) using an iterative reconstruction algo-
rithm. A perfusion defect is visualized indirectly by
perfusion scanning as a parenchymal defect related to the
embolized artery, and is confirmed by combined ventila-
tion scanning, showing a normal regional ventilation.
Blinded from clinical data all scans were indepen-
dently evaluated by two experts according to the
PIOPED (prospective investigation of pulmonary embo-
lism diagnosis) criteria modified for SPECT images, as
described by Reinartz et al [5,9,10]. In scans graded dif-
ferently a consensus read was undertaken. Scans show-
ing at least subsegmental perfusion defects with
corresponding regular ventilation were considered con-
sistent with PE (Figure 1).
Statistical analysis
For analysing factors associated with shunt volume
dynamics in patients suffering of CS non-parametric
data were compared using the Mann-Whitney U-test;
comparisons of dichotomized data were performed by
Fisher’s exact test.
Results
Among 39 patients suffering of CS a reduction in shunt
volume was evident in 27 patients (69.2%). In these
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patients (61.5%) were female. Silent PE (Figure 1) was
demonstrated in 18 patients (46.2%), whereas a DVT
was found only in 3 patients (7.7%). An ASA was found
in 11 patients (28.2%) and in 10 patients (25.6%) a HAS
w a se v i d e n t .F a c t o r ss u c ha sA S A ,D V To rs i l e n tP E
were not associated with a RLS reduction over time
(Table 1). A greater time delay from index event to fol-
low-up assessment was associated with a decrease in
shunt volume (median 12 vs. 6 months, p = 0.013).
In the total cohort of 102 patients investigated with
respect to shunt persistence in 63 patients other causes
for stroke were evident. In these patients a reduction in
RLS was less frequently observed (4/63 vs. 29/39, p <
0.001). Patients with CS were younger (median 40 vs. 63
years, p < 0.001) and had more frequently oral anticoa-
g u l a n t sf o rt h es e c o n d a r ys t r o k ep r e v e n t i o n( 2 8 / 3 9v s .
12/63, p < 0.001) than patients with other determined
stroke aetiologies.
Discussion
In this specific group of patients with cryptogenic stroke
and PFO factors such as the use of oral anticoagulants
for secondary prevention, an associated ASA or silent
PE diagnosed within the stroke work-up on index event
were not associated with a decrease in RLS shunt
volume across a PFO. The time delay from index event
to the follow-up assessment was proven the single factor
determining a decrease in RLS across a PFO, suggesting
the later the follow-up assessment the greater the likeli-
hood for a RLS reduction. However, due to the study
design, there are limitations regarding a precise determi-
nation of a time interval.
A functional PFO opening/closure was observed dur-
ing the course and treatment of an acute massive PE,
suggesting that a pressure fluctuation within the right
atrium might be responsible for this phenomenon [2,3].
Yet it far remains uncertain, whether also a moderate
pressure increase in pulmonary arterial pressure as
induced by silent PE is sufficient to facilitate a change in
RLS across a PFO [11,12]. Considering the high propor-
tion of patients with silent PE among patients with CS
this mechanism appears likely [5]. Despite the plausibil-
ity of such an interrelation, clear evidence that silent PE
is involved in the mechanism of shunt dynamic could
not be derived from our data. However, a definitive
Figure 1 Perfusion defect detected by V/Q (SPECT reconstruction). Regular ventilation left, perfusion defect right (arrow).
Table 1 Factors associated with PFO shunt dynamic in patients with cryptogenic stroke and PFO
Total patient cohort n = 39
(%)
RLS volume change n = 27
(%)
No RLS volume change n = 12
(%)
P
Age (years) median (range) 40.0 (19.7 - 65.2) 42.8 (21.4 - 65.2) 38.1 (19.7 - 64.3) 0.58
Sex 0.47
Female 24 (61.5) 16 (59.3) 8 (66.7)
Male 15 (38.5) 11 (40.7) 4 (33.3)
Use of anticoagulants 28 (71.8) 20 (74.1) 8 (66.7) 0.46
ASA 11 (28.2) 8 (29.6) 3 (25.0) 0.54
HAS 10 (25.6) 6 (22.2) 4 (33.3) 0.36
DVT 3 (7.7) 1 (3.7) 2 (16.7) 0.22
Silent PE 18 (46.2) 12 (44.4) 6 (50.0) 0.51
T0-T1 (months) median/mean
(SD)
12 (6 - 60) 12 (7 - 60) 6 (6 - 25) 0.013
RLS, right to left shunt; ASA, atrial septal aneurysm; HAS, hypermobile atrial septum; DVT, deep vein thrombosis; PE, pulmonary embolism; T0-T1 time delay index
event to follow-up assessment.
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drawn, especially considering the ambiguity, whether the
perfusion defects detected in our study reflect recent
events; the morphological analysis of subsegmental
defects in the V/Q does not allow a precise determina-
tion of the date of onset and all patients were asympto-
matic for PE [5]. A direct involvement in the
pathophysiology of paradoxical embolism and shunt
dynamic remains uncertain. Thus, this limitation needs
to be taken into account when interpreting our results.
Verifying our results appears mandatory as they could
be of immediate relevance. Cuppini et al. found silent
PE in a high percentage of patients admitted with acute
DVT [13]. In the majority of cases perfusion defects
resolved within ten days after anticoagulant treatment.
This suggests high efficacy of an anticoagulant treatment
[13]. Assuming an association between silent PE and
shunt dynamic, an effective treatment of PE could
favourably influence a shunt dynamic: it potentially may
lead to a shunt reduction or even a functional closure.
However, further investigations are of high priority as
a better understanding of the pathophysiology behind
the shunt dynamic across a PFO is of relevance for the
development of new individualized treatment strategies.
In particular, the spontaneous and functional closure of
a PFO would be of major clinical importance, potentially
facilitating an individualised decision for or against an
invasive intervention. Furthermore circumstances which
potential impact on the maintenance of a functionally
“closed” PFO as well as factors involved in the “opening”
of a PFO would be of particular interest as they could
be considered when making recommendations.
The main limitation of the present study is the small
number of patients. However, it represents a unique
analysis in patients with CS and a re-assessment of RLS
on follow-up in association with silent PE. Even though
collected retrospectively, all V/Q scans were indepen-
dently reassessed by two experts, who were blinded
from any clinical data [5].
Conclusions
In patients with CS a reduction in RLS is not associated
with the presence of a venous embolic event such as
DVT or silent PE. A greater time delay for the follow-
up event increases the likelihood for proving a reduction
in RLS on follow-up. A verification of these results
seems mandatory, as they might implicate a high clinical
relevance. A better understanding of the mechanism of
PFO shunt dynamic potentially facilitates new treatment
strategies in the primary as well as in the secondary pre-
vention. Especially the identification of further factors
which maintain a functionally “closed” PFO and particu-
larly of those factors involved in an “opening” mechan-
ism would be of major interest.
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